Literature DB >> 33584342

COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients.

Ricardo Wesley Alberca1, Júlia Cataldo Lima1, Emily Araujo de Oliveira1,2, Sarah Cristina Gozzi-Silva1,2, Yasmim Álefe Leuzzi Ramos1, Milena Mary de Souza Andrade1, Danielle Rosa Beserra1, Luana de Mendonça Oliveira1,2, Anna Cláudia Calvielli Castelo Branco1,2, Anna Julia Pietrobon1,2, Nátalli Zanete Pereira1, Franciane Mouradian Emidio Teixeira1,2, Iara Grigoletto Fernandes1, Alberto José da Silva Duarte1, Gil Benard1, Maria Notomi Sato1.   

Abstract

The severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, the COVID-19 pandemic presents a huge social and health challenge worldwide. Many different risk factors are associated with disease severity, such as systemic arterial hypertension, diabetes mellitus, obesity, older age, and other co-infections. Other respiratory diseases such as chronic obstructive pulmonary disease (COPD) and smoking are common comorbidities worldwide. Previous investigations have identified among COVID-19 patients smokers and COPD patients, but recent investigations have questioned the higher risk among these populations. Nevertheless, previous reports failed to isolate smokers and COPD patients without other comorbidities. We performed a longitudinal evaluation of the disease course of smokers, former smokers, and COPD patients with COVID-19 without other comorbidities, from hospitalization to hospital discharge. Although no difference between groups was observed during hospital admission, smokers and COPD patients presented an increase in COVID-19-associated inflammatory markers during the disease course in comparison to non-smokers and former smokers. Our results demonstrated that smoking and COPD are risk factors for severe COVID-19 with possible implications for the ongoing pandemic.
Copyright © 2021 Alberca, Lima, Oliveira, Gozzi-Silva, Ramos, Andrade, Beserra, Oliveira, Branco, Pietrobon, Pereira, Teixeira, Fernandes, Duarte, Benard and Sato.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; chronic obstructive pulmonary disease; infection; smoking

Year:  2021        PMID: 33584342      PMCID: PMC7873569          DOI: 10.3389/fphys.2020.637627

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  32 in total

1.  Smoking and COPD: What really are the risks?

Authors:  S Marsh; S Aldington; P Shirtcliffe; M Weatherall; R Beasley
Journal:  Eur Respir J       Date:  2006-10       Impact factor: 16.671

2.  Cardiac complications of COVID-19: the concealed realities.

Authors:  Prabhu Dutta Shaw; Arathi P Rao; Parul Malik
Journal:  Infect Dis (Lond)       Date:  2020-11-09

3.  Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study.

Authors:  Raija Auvinen; Hanna Nohynek; Ritva Syrjänen; Jukka Ollgren; Tuija Kerttula; Jarkko Mäntylä; Niina Ikonen; Raisa Loginov; Anu Haveri; Satu Kurkela; Kirsi Skogberg
Journal:  Infect Dis (Lond)       Date:  2020-11-10

4.  Cigarette smoking as a risk factor for influenza-associated mortality: evidence from an elderly cohort.

Authors:  Chit M Wong; Lin Yang; King P Chan; Wai M Chan; Liang Song; Hak K Lai; Thuan Q Thach; Lai M Ho; Kwok H Chan; Tai H Lam; Joseph S M Peiris
Journal:  Influenza Other Respir Viruses       Date:  2012-07-20       Impact factor: 4.380

5.  SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.

Authors:  Helena Barrasa; Jordi Rello; Sofia Tejada; Alejandro Martín; Goiatz Balziskueta; Cristina Vinuesa; Borja Fernández-Miret; Ana Villagra; Ana Vallejo; Ana San Sebastián; Sara Cabañes; Sebastián Iribarren; Fernando Fonseca; Javier Maynar
Journal:  Anaesth Crit Care Pain Med       Date:  2020-04-09       Impact factor: 4.132

Review 6.  The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection.

Authors:  Anna Cláudia Calvielli Castelo Branco; Maria Notomi Sato; Ricardo Wesley Alberca
Journal:  Front Cell Infect Microbiol       Date:  2020-09-23       Impact factor: 5.293

7.  Influence of Cigarettes and Alcohol on the Severity and Death of COVID-19: A Multicenter Retrospective Study in Wuhan, China.

Authors:  Mengyuan Dai; Liyuan Tao; Zhen Chen; Zhi Tian; Xiaofang Guo; Diane S Allen-Gipson; Ruirong Tan; Rui Li; Li Chai; Fen Ai; Miao Liu
Journal:  Front Physiol       Date:  2020-12-09       Impact factor: 4.566

Review 8.  Pregnancy, Viral Infection, and COVID-19.

Authors:  Ricardo Wesley Alberca; Nátalli Zanete Pereira; Luanda Mara Da Silva Oliveira; Sarah Cristina Gozzi-Silva; Maria Notomi Sato
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

9.  The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.

Authors:  Qianwen Zhao; Meng Meng; Rahul Kumar; Yinlian Wu; Jiaofeng Huang; Ningfang Lian; Yunlei Deng; Su Lin
Journal:  J Med Virol       Date:  2020-05-17       Impact factor: 2.327

10.  ACE2 Expression and Risk Factors for COVID-19 Severity in Patients with Advanced Age.

Authors:  Caio de Assis Moura Tavares; Thiago Junqueira Avelino-Silva; Gil Benard; Francisco Akira Malta Cardozo; Juliana Ruiz Fernandes; Adriana Castello Costa Girardi; Wilson Jacob Filho
Journal:  Arq Bras Cardiol       Date:  2020-10       Impact factor: 2.000

View more
  7 in total

1.  The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.

Authors:  Wei Zou; Min Xiong; Siyuan Hao; Elizabeth Yan Zhang; Nathalie Baumlin; Michael D Kim; Matthias Salathe; Ziying Yan; Jianming Qiu
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

2.  SARS-CoV-2 infection in liver transplant recipients: A complex relationship.

Authors:  Ricardo Wesley Alberca; Gil Benard; Gabriela Gama Freire Alberca; Maria Notomi Sato
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

3.  Long-term effects of COVID-19 in diabetic and non-diabetic patients.

Authors:  Ricardo Wesley Alberca; Yasmim Álefe Leuzzi Ramos; Nátalli Zanete Pereira; Danielle Rosa Beserra; Anna Cláudia Calvielli Castelo Branco; Raquel Leão Orfali; Valeria Aoki; Alberto Jose da Silva Duarte; Maria Notomi Sato
Journal:  Front Public Health       Date:  2022-08-15

4.  Post-Acute COVID-19 Sequelae in a Working Population at One Year Follow-Up: A Wide Range of Impacts from an Italian Sample.

Authors:  Danilo Buonsenso; Maria Rosaria Gualano; Maria Francesca Rossi; Angelica Valz Gris; Leuconoe Grazia Sisti; Ivan Borrelli; Paolo Emilio Santoro; Antonio Tumminello; Carolina Gentili; Walter Malorni; Piero Valentini; Walter Ricciardi; Umberto Moscato
Journal:  Int J Environ Res Public Health       Date:  2022-09-05       Impact factor: 4.614

5.  Clinical Characteristics and Survival Analysis in Frequent Alcohol Consumers With COVID-19.

Authors:  Ricardo Wesley Alberca; Paula Ordonhez Rigato; Yasmim Álefe Leuzzi Ramos; Franciane Mouradian Emidio Teixeira; Anna Cláudia Calvielli Branco; Iara Grigoletto Fernandes; Anna Julia Pietrobon; Alberto Jose da Silva Duarte; Valeria Aoki; Raquel Leão Orfali; Maria Notomi Sato
Journal:  Front Nutr       Date:  2021-06-02

Review 6.  Asthma and COVID-19: a dangerous liaison?

Authors:  Carlo Lombardi; Federica Gani; Alvise Berti; Pasquale Comberiati; Diego Peroni; Marcello Cottini
Journal:  Asthma Res Pract       Date:  2021-07-15

7.  Role of vitamin D deficiency and comorbidities in COVID-19.

Authors:  Gabriela Gama Freire Alberca; Ricardo Wesley Alberca
Journal:  World J Virol       Date:  2022-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.